-+ 0.00%
-+ 0.00%
-+ 0.00%

CINGULATE COMPLETES PRE-NDA MEETING WITH FDA TO DISCUSS NEW DRUG APPLICATION FOR LEAD ADHD ASSET CTX-1301

Reuters·04/03/2025 12:00:03

Please log in to view news